Buy­ing time to catch up on sales, ADC Ther­a­peu­tics takes on $175M loan

With sales of its first an­ti­body-drug con­ju­gate falling be­low ex­pec­ta­tions, ADC Ther­a­peu­tics is tak­ing on a $175 mil­lion loan and buy­ing it­self some time. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER